{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:06:42Z","timestamp":1778425602743,"version":"3.51.4"},"reference-count":54,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.1001\/jamacardio.2021.5916","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T16:03:41Z","timestamp":1645027421000},"page":"435","source":"Crossref","is-referenced-by-count":15,"title":["Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis"],"prefix":"10.1001","volume":"7","author":[{"given":"Edina","family":"Hadziselimovic","sequence":"first","affiliation":[{"name":"Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders M.","family":"Greve","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry 3011, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Sajadieh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Holb\u00e6k Hospital, Holb\u00e6k, Denmark"},{"name":"Department of Regional Health Research, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. Antero","family":"Kes\u00e4niemi","sequence":"additional","affiliation":[{"name":"Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph A.","family":"Nienaber","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield NHS Foundation Trust, Imperial College, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon G.","family":"Ray","sequence":"additional","affiliation":[{"name":"Manchester Academic Health Sciences Centre, Manchester, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne B.","family":"Rosseb\u00f8","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oslo, Oslo University Hospital, Ullev\u00e5l, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnie","family":"Willenheimer","sequence":"additional","affiliation":[{"name":"Lund University, Heart Health Group, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Wachtell","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olav W.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark"},{"name":"Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"key":"hoi210094r1","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab626","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease.","author":"Vahanian","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"hoi210094r2","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"11","key":"hoi210094r3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study.","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"hoi210094r4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/heartjnl-2012-302265","article-title":"The evolving epidemiology of valvular aortic stenosis. the Troms\u00f8 study.","volume":"99","author":"Eveborn","year":"2013","journal-title":"Heart"},{"issue":"9540","key":"hoi210094r5","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","article-title":"Burden of valvular heart diseases: a population-based study.","volume":"368","author":"Nkomo","year":"2006","journal-title":"Lancet"},{"issue":"4","key":"hoi210094r6","first-page":"e29","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association.","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"issue":"15","key":"hoi210094r9","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.jacc.2019.08.004","article-title":"Poor long-term survival in patients with moderate aortic stenosis.","volume":"74","author":"Strange","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"hoi210094r10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/eurheartj\/ehv525","article-title":"A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis.","volume":"37","author":"Chin","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"hoi210094r11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.echo.2020.11.015","article-title":"Excess mortality associated with progression rate in asymptomatic aortic valve stenosis.","volume":"34","author":"Benfari","year":"2021","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"hoi210094r12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.echo.2020.10.012","article-title":"Prognostic risk stratification of patients with moderate aortic stenosis.","volume":"34","author":"Ito","year":"2021","journal-title":"J Am Soc Echocardiogr"},{"issue":"8","key":"hoi210094r13","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide.","volume":"97","author":"Tamura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"hoi210094r14","doi-asserted-by":"publisher","first-page":"H777","DOI":"10.1152\/ajpheart.00117.2005","article-title":"Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.","volume":"289","author":"Patel","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"hoi210094r15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1172\/JCI108079","article-title":"Wall stress and patterns of hypertrophy in the human left ventricle.","volume":"56","author":"Grossman","year":"1975","journal-title":"J Clin Invest"},{"issue":"19","key":"hoi210094r16","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1016\/j.jacc.2012.02.093","article-title":"Calcific aortic stenosis: a disease of the valve and the myocardium.","volume":"60","author":"Dweck","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"hoi210094r17","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.jacc.2004.09.038","article-title":"Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy.","volume":"44","author":"Vanderheyden","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"hoi210094r18","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/j.ehj.2004.09.033","article-title":"Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.","volume":"25","author":"Lim","year":"2004","journal-title":"Eur Heart J"},{"issue":"3","key":"hoi210094r19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.amjcard.2009.09.043","article-title":"Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis.","volume":"105","author":"Lancellotti","year":"2010","journal-title":"Am J Cardiol"},{"issue":"6","key":"hoi210094r20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.amjcard.2004.05.055","article-title":"Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.","volume":"94","author":"Weber","year":"2004","journal-title":"Am J Cardiol"},{"issue":"7","key":"hoi210094r21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.amjcard.2004.11.053","article-title":"Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration.","volume":"95","author":"Gerber","year":"2005","journal-title":"Am J Cardiol"},{"issue":"7","key":"hoi210094r22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/heartjnl-2012-303284","article-title":"Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study.","volume":"99","author":"Cimadevilla","year":"2013","journal-title":"Heart"},{"key":"hoi210094r23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijcard.2016.12.100","article-title":"Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis.","volume":"230","author":"Nguyen","year":"2017","journal-title":"Int J Cardiol"},{"issue":"1","key":"hoi210094r24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0022-3859.39183","article-title":"Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.","volume":"54","author":"Cemri","year":"2008","journal-title":"J Postgrad Med"},{"issue":"19","key":"hoi210094r25","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.jacc.2014.02.581","article-title":"B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival.","volume":"63","author":"Clavel","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"hoi210094r26","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1161\/01.CIR.0000126825.50903.18","article-title":"Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.","volume":"109","author":"Bergler-Klein","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"hoi210094r27","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.amjcard.2020.02.004","article-title":"Prognostic value of N-terminal pro-form B-type natriuretic peptide in patients with moderate aortic stenosis.","volume":"125","author":"Ito","year":"2020","journal-title":"Am J Cardiol"},{"issue":"14","key":"hoi210094r28","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jacc.2020.02.031","article-title":"Prognostic value of N-terminal pro-B-type natriuretic peptide in elderly patients with valvular heart disease.","volume":"75","author":"Zhang","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"hoi210094r29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.amjcard.2006.10.064","article-title":"Design and baseline characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.","volume":"99","author":"Rosseb\u00f8","year":"2007","journal-title":"Am J Cardiol"},{"issue":"13","key":"hoi210094r30","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"issue":"20","key":"hoi210094r31","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"hoi210094r32","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"hoi210094r34","first-page":"230","article-title":"Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.","volume":"28","author":"Vahanian","year":"2007","journal-title":"Eur Heart J"},{"issue":"5","key":"hoi210094r35","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1161\/CIRCULATIONAHA.106.176857","article-title":"ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.","volume":"114","author":"Bonow","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"hoi210094r36","first-page":"309","article-title":"Valvular heart disease: recommendations for investigation and management: summary of guidelines produced by a working group of the British Cardiac Society and the Research Unit of the Royal College of Physicians.","volume":"30","author":"Prendergast","year":"1996","journal-title":"J R Coll Physicians Lond"},{"issue":"3","key":"hoi210094r37","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0735-1097(99)00351-4","article-title":"1999 update: ACC\/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).","volume":"34","author":"Ryan","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"hoi210094r38","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0735-1097(01)01344-4","article-title":"ACC\/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty).","volume":"37","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"hoi210094r39","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000037106.76139.53","article-title":"ACC\/AHA guideline update for the management of patients with unstable angina and non\u2013ST-segment elevation myocardial infarction\u20142002: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"hoi210094r40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.0000134791.68010.FA","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction\u2014executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).","volume":"110","author":"Antman","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"hoi210094r41","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/j.jacc.2004.07.021","article-title":"ACC\/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article\u2014a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).","volume":"44","author":"Eagle","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"hoi210094r42","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1093\/eurheartj\/ehi138","article-title":"Guidelines for percutaneous coronary interventions.","volume":"26","author":"Silber","year":"2005","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi210094r43","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2005.12.001","article-title":"ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention).","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hoi210094r44","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/eurheartj\/ehi236","article-title":"Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.","volume":"26","author":"Weber","year":"2005","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi210094r45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/CIRCULATIONAHA.108.808857","article-title":"Risk score for predicting outcome in patients with asymptomatic aortic stenosis.","volume":"120","author":"Monin","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"hoi210094r46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.recesp.2013.06.023","article-title":"Prognostic value of NT-proBNP and an adapted Monin score in patients with asymptomatic aortic stenosis.","volume":"67","author":"Farr\u00e9","year":"2014","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"7","key":"hoi210094r47","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/heart.89.7.745","article-title":"The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.","volume":"89","author":"Raymond","year":"2003","journal-title":"Heart"},{"issue":"3","key":"hoi210094r48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.36.3.355","article-title":"Deconvolution analysis of cardiac natriuretic peptides during acute volume overload.","volume":"36","author":"Pemberton","year":"2000","journal-title":"Hypertension"},{"issue":"8","key":"hoi210094r49","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1515\/CCLM.2004.153","article-title":"Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples.","volume":"42","author":"Mueller","year":"2004","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"hoi210094r50","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1515\/cclm-2019-1320","article-title":"Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study.","volume":"58","author":"van den Berg","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"hoi210094r51","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001040","article-title":"Biological variation of cardiac markers in patients with aortic valve stenosis.","volume":"6","author":"Peeters","year":"2019","journal-title":"Open Heart"},{"issue":"2","key":"hoi210094r52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cjca.2015.06.007","article-title":"Impact of serial B-type natriuretic peptide changes for predicting outcome in asymptomatic patients with aortic stenosis.","volume":"32","author":"Henri","year":"2016","journal-title":"Can J Cardiol"},{"key":"hoi210094r53","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cca.2013.03.025","article-title":"Short- and long-term individual variation in NT-proBNP levels in patients with stable coronary artery disease.","volume":"422","author":"Nordenskj\u00f6ld","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"1","key":"hoi210094r54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"hoi210094r7","unstructured":"The World Bank. Population ages 65 and above (% of total population). Accessed June 23, 2021. https:\/\/data.worldbank.org\/indicator\/SP.POP.65UP.TO.ZS"},{"key":"hoi210094r8","unstructured":"The United Nations. Department of Economic and Social Affairs. Population Dynamics: World Population Prospects 2019. Population growth rate. Accessed June 23, 2021.https:\/\/population.un.org\/wpp\/Maps\/"},{"key":"hoi210094r33","unstructured":"COBAS. Elecsys proBNP II, ref. 04842464 190, V 12.0 English, 2017. Accessed January 23, 2022. https:\/\/labogids.sintmaria.be\/sites\/default\/files\/files\/probnp_ii_2017-08_v12.pdf"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2788912\/jamacardiology_hadziselimovic_2022_oi_210094_1648745326.05604.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T15:11:09Z","timestamp":1649862669000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2788912"}},"subtitle":["A Post Hoc Substudy of the SEAS Trial"],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2021.5916","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}